LATHAM, N.Y.--(BUSINESS WIRE)--Sep. 13, 2018--
AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative,
minimally invasive medical devices for vascular access, peripheral
vascular disease, and oncology, today announced that it will report
financial results for the first quarter of fiscal year 2019 before the
market open on Thursday, September 27, 2018. The Company’s management
will host a conference call at 8:00 a.m. ET the same day to discuss the
To participate in the conference call, dial 1-877-407-0784 (domestic) or
1-201-689-8560 (international) and refer to the passcode 13683219.
This conference call will also be webcast and can be accessed from the
“Investors” section of the AngioDynamics website at www.angiodynamics.com.
The webcast replay of the call will be available at the same site
approximately one hour after the end of the call.
A recording of the call will also be available from 11:00 a.m. ET on
Thursday, September 27, 2018, until 11:59 p.m. ET on Thursday, October
4, 2018. To hear this recording, dial 1-844-512-2921 (domestic) or
1-412-317-6671 (international) and enter the passcode 13683219.
About AngioDynamics, Inc.
AngioDynamics, Inc. is a leading provider of innovative, minimally
invasive medical devices used by professional healthcare providers for
vascular access, peripheral vascular disease, and oncology.
AngioDynamics’ diverse product lines include market-leading ablation
systems, fluid management systems, vascular access products,
angiographic products and accessories drainage products, thrombolytic
products and venous products. For more information, visit www.angiodynamics.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180913005916/en/
Source: AngioDynamics, Inc.
Michael Greiner, 518-795-1821
Vice President & CFO